MENU
+Compare
SRDX
Stock ticker: NASDAQ
AS OF
Nov 13, 04:59 PM (EDT)
Price
$41.41
Change
+$0.06 (+0.15%)
Capitalization
592.06M

SRDX Surmodics Forecast, Technical & Fundamental Analysis

Surmodics Inc is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays... Show more

SRDX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for SRDX with price predictions
Nov 12, 2025

Momentum Indicator for SRDX turns positive, indicating new upward trend

SRDX saw its Momentum Indicator move above the 0 level on November 11, 2025. This is an indication that the stock could be shifting in to a new upward move. Traders may want to consider buying the stock or buying call options. Tickeron's A.I.dvisor looked at 87 similar instances where the indicator turned positive. In of the 87 cases, the stock moved higher in the following days. The odds of a move higher are at .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Moving Average Convergence Divergence (MACD) for SRDX just turned positive on October 17, 2025. Looking at past instances where SRDX's MACD turned positive, the stock continued to rise in of 51 cases over the following month. The odds of a continued upward trend are .

SRDX moved above its 50-day moving average on November 11, 2025 date and that indicates a change from a downward trend to an upward trend.

The 10-day moving average for SRDX crossed bullishly above the 50-day moving average on November 12, 2025. This indicates that the trend has shifted higher and could be considered a buy signal. In of 13 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are .

Following a +5 3-day Advance, the price is estimated to grow further. Considering data from situations where SRDX advanced for three days, in of 290 cases, the price rose further within the following month. The odds of a continued upward trend are .

Bearish Trend Analysis

The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

The 50-day moving average for SRDX moved below the 200-day moving average on October 27, 2025. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where SRDX declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

SRDX broke above its upper Bollinger Band on November 11, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for SRDX entered a downward trend on November 10, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. SRDX’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Seasonality Score of (best 1 - 100 worst) indicates that the company is fair valued in the industry. The Tickeron Seasonality score describes the variance of predictable price changes around the same period every calendar year. These changes can be tied to a specific month, quarter, holiday or vacation period, as well as a meteorological or growing season.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (5.319) is normal, around the industry mean (63.534). P/E Ratio (43.229) is within average values for comparable stocks, (37.086). SRDX's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (1.687). SRDX has a moderately low Dividend Yield (0.000) as compared to the industry average of (0.019). P/S Ratio (4.883) is also within normal values, averaging (79.919).

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SRDX’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 93, placing this stock worse than average.

View a ticker or compare two or three
SRDX
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

SRDX is expected to report earnings to fall 316.67% to -12 cents per share on February 10

Surmodics SRDX Stock Earnings Reports
Q4'25
Est.
$-0.13
Q2'25
Beat
by $0.25
Q1'25
Missed
by $0.04
Q4'24
Beat
by $0.08
Q3'24
Beat
by $0.07
The last earnings report on August 08 showed earnings per share of 5 cents, beating the estimate of -18 cents. With 275.67K shares outstanding, the current market capitalization sits at 592.06M.
A.I. Advisor
published General Information

General Information

a provider of surface modification and in vitro diagnostic technologies to the healthcare industry

Industry MedicalNursingServices

Profile
Fundamentals
Details
Industry
Medical Specialties
Address
9924 West 74th Street
Phone
+1 952 500-7000
Employees
376
Web
https://www.surmodics.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
HIISX16.380.04
+0.24%
Harbor International Small Cap Investor
SVSPX300.010.21
+0.07%
State Street S&P 500 Index N
CPCCX4.12N/A
N/A
Comstock Capital Value C
FERCX54.21N/A
N/A
Fidelity Advisor Emerging Asia C
OTFCX47.65-0.19
-0.40%
Invesco Discovery Large Cap C

SRDX and Stocks

Correlation & Price change

A.I.dvisor tells us that SRDX and BDX have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that SRDX and BDX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRDX
1D Price
Change %
SRDX100%
+1.00%
BDX - SRDX
32%
Poorly correlated
+1.64%
ALGN - SRDX
31%
Poorly correlated
-1.94%
SIBN - SRDX
30%
Poorly correlated
-1.21%
BLCO - SRDX
29%
Poorly correlated
+1.03%
ATRC - SRDX
28%
Poorly correlated
+0.61%
More

Groups containing SRDX

Correlation & Price change

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRDX
1D Price
Change %
SRDX100%
+1.00%
Medical/Nursing Services
industry (215 stocks)
25%
Poorly correlated
-2.32%
Health Services
industry (422 stocks)
-1%
Poorly correlated
-2.10%